Could Vitamins Have a Positive Impact on the Treatment of Parkinson’s Disease?

Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder after Alzheimer’s disease. Pathophysiologically, it is characterized by intracytoplasmic aggregates of α-synuclein protein in the Lewy body and loss of dopaminergic neurons from substantia nigra pars compacta a...

Descripción completa

Detalles Bibliográficos
Autores principales: , Sandeep, Sahu, Manas Ranjan, Rani, Linchi, Kharat, Arun S., Mondal, Amal Chandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954544/
https://www.ncbi.nlm.nih.gov/pubmed/36831815
http://dx.doi.org/10.3390/brainsci13020272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954544/
https://www.ncbi.nlm.nih.gov/pubmed/36831815
http://dx.doi.org/10.3390/brainsci13020272

Ejemplares similares